ARCHIVES

DCCP Board Approves Concepts For Three New RFAs, Contract Recompetitions

This article is from The Cancer Letter archive.

Vol. 08 No. 23 | June 4, 1982

Download PDF Visit The Full Archive

Related Articles

Amgen Announces Cochrane Findings: ESAs Increase Risk Of On-Study Death.

October 3, 2008

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

January 25, 2013

NCI Advisors Approve Expansion Of CCOPs, Minority-Based CCOPs; Approve Reissuance Of BMT Network RFA, RFPs For Preclinical Drug Studies

November 13, 2009

House Committee Investigates ESA Safety, Urges Amgen, J&J, To Stop Promotions.

March 23, 2007

Low-Dose IFN Not Effective Against Melanoma, Study Finds

December 26, 2003

ASCO Explores White, Minority Cancer Problem

July 13, 1990